REGENXBIO Inc. (RGNX)
NASDAQ: RGNX · Real-Time Price · USD
9.63
+0.07 (0.73%)
At close: Nov 20, 2024, 4:00 PM
9.35
-0.28 (-2.91%)
Pre-market: Nov 21, 2024, 7:39 AM EST
REGENXBIO Market Cap
REGENXBIO has a market cap or net worth of $477.12 million as of November 21, 2024. Its market cap has decreased by -31.26% in one year.
Market Cap
477.12M
Enterprise Value
344.36M
1-Year Change
-31.26%
Ranking
Category
Stock Price
$9.63
Market Cap Chart
Since September 17, 2015, REGENXBIO's market cap has decreased from $749.30M to $477.12M, a decrease of -36.32%. That is a compound annual growth rate of -4.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2024 | 473.70M | -40.02% |
| Dec 29, 2023 | 789.70M | -19.57% |
| Dec 30, 2022 | 981.90M | -29.79% |
| Dec 31, 2021 | 1.40B | -17.57% |
| Dec 31, 2020 | 1.70B | 12.32% |
| Dec 31, 2019 | 1.51B | 0.48% |
| Dec 31, 2018 | 1.50B | 45.18% |
| Dec 29, 2017 | 1.04B | 110.87% |
| Dec 30, 2016 | 491.10M | 12.43% |
| Dec 31, 2015 | 436.80M | -41.71% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Pharming Group | 511.58M |
| Fulgent Genetics | 511.11M |
| Altimmune | 508.54M |
| Savara | 507.99M |
| Talkspace | 505.08M |
| Mind Medicine (MindMed) | 501.59M |
| PureTech Health | 498.29M |
| Olema Pharmaceuticals | 494.13M |